Stockscreener 앱 받기
1.40
22.81%
0.26
시간 외 거래:
1.36
-0.04
-2.86%
Context Therapeutics Inc 주식(CNTX)의 최신 뉴스
How Context Therapeutics Inc. stock trades before earningsQuarterly Profit Summary & Consistent Growth Stock Picks - newser.com
Real time social sentiment graph for Context Therapeutics Inc.Gap Up & Weekly Setup with High ROI Potential - newser.com
Live market analysis of Context Therapeutics Inc.Weekly Stock Summary & Expert Curated Trade Setup Alerts - newser.com
Is a relief rally coming for Context Therapeutics Inc. holdersIndex Update & AI Driven Stock Reports - newser.com
Can a trend reversal in Context Therapeutics Inc. lead to recovery2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Is Context Therapeutics Inc. showing signs of accumulationEarnings Summary Report & Stepwise Trade Signal Implementation - newser.com
Context Therapeutics to Showcase CT-95 Data at AACR 2025 - MSN
Institutions profited after Context Therapeutics Inc.'s (NASDAQ:CNTX) market cap rose US$14m last week but private equity firms profited the most - Yahoo
Context Therapeutics Inc. (NASDAQ:CNTX) Receives $5.20 Consensus PT from Analysts - Defense World
Context Therapeutics Grants Stock Options to New Hire - MSN
Will Context Therapeutics Inc. see short term momentumJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com
Context Therapeutics Announces Poster Presentations at the - GlobeNewswire
Context Therapeutics Inc. to Present Trial Progress and Preclinical Data at SITC 2025 Annual Meeting - Quiver Quantitative
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of ... - Caledonian Record
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting - Stock Titan
Context Therapeutics Inc. stock momentum explainedWeekly Stock Analysis & Fast Momentum Stock Entry Tips - newser.com
Is it too late to sell Context Therapeutics Inc.2025 Winners & Losers & High Win Rate Trade Tips - newser.com
Context Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(4) - MarketScreener
Developing predictive dashboards with Context Therapeutics Inc. dataJuly 2025 Update & AI Forecasted Entry/Exit Points - newser.com
Context Therapeutics Inc. (NASDAQ:CNTX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Context Therapeutics announces inducement grant under Nasdaq listing rule - MarketScreener
GlobeNewswire by Notified - The Manila Times
Spyre Therapeutics Announces Grants of Inducement Awards - The Manila Times
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
30,000-Share Option: Context Therapeutics Grants New Hire Award at $0.97 Exercise Price, 10-year Term - Stock Titan
Context Therapeutics Gains 11%, Insider Trades Reap Benefit - simplywall.st
Is Context Therapeutics Inc. stock in correction or buying zoneWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
Cantor Fitzgerald Initiates Coverage of Context Therapeutics (CNTX) with Overweight Recommendation - Nasdaq
This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday - Benzinga
What analysts say about Context Therapeutics Inc stockPortfolio Diversification Tips & Tap Into the Fastest-Growing Companies - earlytimes.in
0.74%
1.60%
자본화:
|
볼륨(24시간):